SE9703691D0 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- SE9703691D0 SE9703691D0 SE9703691A SE9703691A SE9703691D0 SE 9703691 D0 SE9703691 D0 SE 9703691D0 SE 9703691 A SE9703691 A SE 9703691A SE 9703691 A SE9703691 A SE 9703691A SE 9703691 D0 SE9703691 D0 SE 9703691D0
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical formulations
- medium chain
- bisphosphonate
- osteoporosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703691A SE9703691D0 (sv) | 1997-10-10 | 1997-10-10 | Pharmaceutical compositions |
ZA988886A ZA988886B (en) | 1997-10-10 | 1998-09-29 | Formulation for treatment of osteoporosis |
EP03001707A EP1310259A3 (en) | 1997-10-10 | 1998-10-05 | Formulation comprising a biphosphonate and an absorption enhancing agent for the treatment of osteoporosis |
AU94691/98A AU9469198A (en) | 1997-10-10 | 1998-10-05 | New improved formulation for treatment of osteoporosis |
SI9830488T SI1021194T1 (en) | 1997-10-10 | 1998-10-05 | New improved formulation for treatment of osteoporosis |
ES98948029T ES2200378T3 (es) | 1997-10-10 | 1998-10-05 | Nueva formulacion mejorada para el tratamiento de la osteoporosis. |
PT98948029T PT1021194E (pt) | 1997-10-10 | 1998-10-05 | Nova formulacao melhorada para tratamento da osteoporose |
EP98948029A EP1021194B1 (en) | 1997-10-10 | 1998-10-05 | New improved formulation for treatment of osteoporosis |
DE69814656T DE69814656T2 (de) | 1997-10-10 | 1998-10-05 | Neue verbesserte formulierung zur behandlung der osteoporose |
ARP980104956A AR015946A1 (es) | 1997-10-10 | 1998-10-05 | Formulacion farmaceutica que comprende bifosfonatos, proceso para su preparacion, uso de la formulacion para la fabricacion de un medicamento, metodo parala inhibicion de la reabsorcion osea, y metodo para el tratamiento y prevencion de osteoporosis |
DK98948029T DK1021194T3 (da) | 1997-10-10 | 1998-10-05 | Ny forbedret formulering til behandling af osteoporose |
JP2000515605A JP2001519398A (ja) | 1997-10-10 | 1998-10-05 | 骨粗鬆症の治療のための新規な改良された処方物 |
AT98948029T ATE240107T1 (de) | 1997-10-10 | 1998-10-05 | Neue verbesserte formulierung zur behandlung der osteoporose |
PCT/SE1998/001790 WO1999018972A1 (en) | 1997-10-10 | 1998-10-05 | New improved formulation for treatment of osteoporosis |
US09/171,950 US6372728B1 (en) | 1997-10-10 | 1998-10-05 | Formulation for treatment of osteoporosis |
SA98190775A SA98190775A (ar) | 1997-10-10 | 1998-11-18 | صيغة جديدة مطورة لعلاج تخلخل العظام |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703691A SE9703691D0 (sv) | 1997-10-10 | 1997-10-10 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9703691D0 true SE9703691D0 (sv) | 1997-10-10 |
Family
ID=20408561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9703691A SE9703691D0 (sv) | 1997-10-10 | 1997-10-10 | Pharmaceutical compositions |
Country Status (14)
Country | Link |
---|---|
US (1) | US6372728B1 (ja) |
EP (2) | EP1310259A3 (ja) |
JP (1) | JP2001519398A (ja) |
AR (1) | AR015946A1 (ja) |
AT (1) | ATE240107T1 (ja) |
AU (1) | AU9469198A (ja) |
DE (1) | DE69814656T2 (ja) |
DK (1) | DK1021194T3 (ja) |
ES (1) | ES2200378T3 (ja) |
PT (1) | PT1021194E (ja) |
SA (1) | SA98190775A (ja) |
SE (1) | SE9703691D0 (ja) |
WO (1) | WO1999018972A1 (ja) |
ZA (1) | ZA988886B (ja) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1057488A4 (en) * | 1998-12-25 | 2003-10-22 | Toray Industries | INTERLEUKIN-6 PRODUCTION INHIBITORS |
US8119159B2 (en) * | 1999-02-22 | 2012-02-21 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
US20070148228A1 (en) * | 1999-02-22 | 2007-06-28 | Merrion Research I Limited | Solid oral dosage form containing an enhancer |
US7658938B2 (en) | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
SE9901272D0 (sv) * | 1999-04-09 | 1999-04-09 | Astra Ab | New improved formulation |
EP1591122B1 (en) * | 2000-06-20 | 2012-09-26 | Novartis AG | Method of administering bisphosphonates |
MXPA02012682A (es) * | 2000-06-20 | 2003-04-25 | Novartis Ag | Metodo para administrar bisfosfonatos. |
US6638920B2 (en) * | 2000-07-21 | 2003-10-28 | Merck & Co., Inc. | Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses |
AU2002330692A1 (en) * | 2001-07-02 | 2003-01-21 | Elan Corporation, Plc. | Delivery of a bioactive material |
JP4546704B2 (ja) * | 2002-02-14 | 2010-09-15 | 救急薬品工業株式会社 | 経皮投与製剤 |
US7820197B2 (en) | 2002-02-14 | 2010-10-26 | Astellas Pharma Inc. | Percutaneous preparations |
DK1880744T3 (en) | 2002-05-10 | 2015-02-09 | Hoffmann La Roche | Bisphosphonic acids for the treatment and prevention of osteoporosis |
ITMI20032175A1 (it) * | 2003-11-11 | 2005-05-12 | Tiberio Bruzzese | Formulazioni farmaceutiche di bisfosfonati destinate |
US20050182028A1 (en) * | 2004-02-13 | 2005-08-18 | Chen Chih-Ming J. | Pharmaceutical formulation for oral delivery of bisphosphates |
NZ551118A (en) * | 2004-05-24 | 2010-09-30 | Warner Chilcott Co Llc | Enteric solid oral dosage form of bisphosphonate containing a chelating agent |
US7358361B2 (en) * | 2004-10-08 | 2008-04-15 | The Board Of Trustees Of The University Of Illinois | Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
WO2008128056A1 (en) * | 2004-10-08 | 2008-10-23 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps |
CA2603649C (en) * | 2005-04-08 | 2014-10-14 | Ozpharma Pty Ltd | Buccal delivery system |
US7473684B2 (en) * | 2005-09-16 | 2009-01-06 | Selamine Limited | Bisphosphonate formulation |
CA2646334A1 (en) * | 2006-03-17 | 2007-09-27 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods |
EP2526950A1 (en) * | 2006-04-07 | 2012-11-28 | Merrion Research III Limited | Solid oral dosage form containing an enhancer |
JPWO2007132714A1 (ja) * | 2006-05-16 | 2009-09-24 | 日清オイリオグループ株式会社 | 骨密度増加剤 |
US20070292512A1 (en) * | 2006-06-09 | 2007-12-20 | Merrion Research Ii Limited | Solid Oral Dosage Form Containing an Enhancer |
GB0616794D0 (en) | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
US20080139514A1 (en) * | 2006-11-29 | 2008-06-12 | Subhash Pandurang Gore | Diphosphonic acid pharmaceutical compositions |
GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
US8974801B2 (en) * | 2006-12-21 | 2015-03-10 | Amphastar Pharmaceuticals Inc. | Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate |
MX2010012201A (es) | 2008-05-07 | 2011-05-30 | Merrion Res Iii Ltd | Composiciones de péptidos y procedimientos de preparación de las mismas. |
TWI480286B (zh) * | 2009-02-25 | 2015-04-11 | Merrion Res Iii Ltd | 雙膦酸鹽類組合物及藥物遞送 |
US20110182985A1 (en) * | 2010-01-28 | 2011-07-28 | Coughlan David C | Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof |
WO2011120033A1 (en) * | 2010-03-26 | 2011-09-29 | Merrion Research Iii Limited | Pharmaceutical compositions of selective factor xa inhibitors for oral administration |
BR112013017169A2 (pt) | 2011-01-07 | 2016-10-04 | Merrion Res Iii Ltd | composições farmacêuticas de ferro para administração oral |
CN107205948B (zh) | 2015-01-29 | 2021-12-14 | 诺和诺德股份有限公司 | 包含glp-1激动剂和肠溶衣的片剂 |
CN105267145B (zh) * | 2015-11-01 | 2019-06-21 | 袁旭东 | 双膦酸盐的自乳化配方和相关剂型 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL175882C (nl) * | 1977-03-28 | Procter & Gamble | Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat. | |
GB8618259D0 (en) * | 1986-07-25 | 1986-09-03 | Leo Pharm Prod Ltd | Pharmaceutical compositions |
MX21452A (es) * | 1989-07-07 | 1994-01-31 | Ciba Geigy Ag | Preparaciones farmaceuticas que se administran en forma topica. |
DE69023844T2 (de) * | 1989-09-06 | 1996-06-20 | Merck & Co Inc | Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren. |
SE9003100D0 (sv) | 1990-09-28 | 1990-09-28 | Kabivitrum Ab | Lipid formulation system |
US5391743A (en) * | 1992-05-29 | 1995-02-21 | Procter & Gamble Pharmaceuticals, Inc. | Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque |
EP0684834A4 (en) | 1993-02-17 | 1996-09-25 | Smithkline Beecham Corp | MICROEMULSIONS CONTAINING THERAPEUTIC PEPTIDES. |
JP3411690B2 (ja) * | 1994-09-21 | 2003-06-03 | 帝人株式会社 | 局所投与用アレンドロン酸ナトリウム製剤 |
GB9516268D0 (en) * | 1995-08-08 | 1995-10-11 | Danbiosyst Uk | Compositiion for enhanced uptake of polar drugs from the colon |
-
1997
- 1997-10-10 SE SE9703691A patent/SE9703691D0/xx unknown
-
1998
- 1998-09-29 ZA ZA988886A patent/ZA988886B/xx unknown
- 1998-10-05 JP JP2000515605A patent/JP2001519398A/ja active Pending
- 1998-10-05 DK DK98948029T patent/DK1021194T3/da active
- 1998-10-05 US US09/171,950 patent/US6372728B1/en not_active Expired - Fee Related
- 1998-10-05 DE DE69814656T patent/DE69814656T2/de not_active Expired - Lifetime
- 1998-10-05 AT AT98948029T patent/ATE240107T1/de active
- 1998-10-05 AR ARP980104956A patent/AR015946A1/es not_active Application Discontinuation
- 1998-10-05 PT PT98948029T patent/PT1021194E/pt unknown
- 1998-10-05 EP EP03001707A patent/EP1310259A3/en not_active Withdrawn
- 1998-10-05 AU AU94691/98A patent/AU9469198A/en not_active Abandoned
- 1998-10-05 WO PCT/SE1998/001790 patent/WO1999018972A1/en active IP Right Grant
- 1998-10-05 EP EP98948029A patent/EP1021194B1/en not_active Expired - Lifetime
- 1998-10-05 ES ES98948029T patent/ES2200378T3/es not_active Expired - Lifetime
- 1998-11-18 SA SA98190775A patent/SA98190775A/ar unknown
Also Published As
Publication number | Publication date |
---|---|
EP1310259A3 (en) | 2003-05-21 |
ZA988886B (en) | 1999-04-12 |
JP2001519398A (ja) | 2001-10-23 |
EP1310259A2 (en) | 2003-05-14 |
DE69814656T2 (de) | 2004-03-25 |
AR015946A1 (es) | 2001-05-30 |
DE69814656D1 (de) | 2003-06-18 |
EP1021194B1 (en) | 2003-05-14 |
US6372728B1 (en) | 2002-04-16 |
SA98190775A (ar) | 2005-12-03 |
DK1021194T3 (da) | 2003-09-01 |
PT1021194E (pt) | 2003-09-30 |
WO1999018972A1 (en) | 1999-04-22 |
ES2200378T3 (es) | 2004-03-01 |
EP1021194A1 (en) | 2000-07-26 |
AU9469198A (en) | 1999-05-03 |
ATE240107T1 (de) | 2003-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9703691D0 (sv) | Pharmaceutical compositions | |
SE9901272D0 (sv) | New improved formulation | |
IL149681A0 (en) | Polymorphic form of atorvstatin calcium | |
TR200101103T2 (tr) | CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar | |
BR9809793A (pt) | Monoésteres de probucol para o tratamento de doença inflamatória e cardiovascular | |
SI1663185T1 (sl) | Preprečevanje in zdravljenje z vnetjem inducirane in/ali imunsko posredovane izgube kosti | |
PT1047406E (pt) | Composicoes farmaceuticas autoclavaveis contendo um agente quelante | |
ATE212846T1 (de) | Bisphosphonat und anti-resorption agentien, enthaltende zusammensetzungen zur hemmung der knochenschwund | |
EE200000741A (et) | Kompositsioon osteoporoosi ja menopausi sündroomist tingitud muutuste ennetamiseks ja/või raviks | |
DK0639577T3 (da) | Phosphonooxymethyl- eller methylthiomethylestere af taxanderivater som antitumormidler | |
DK0679393T3 (da) | Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol | |
ES2193919T3 (es) | Inhibidores de la enzima convertidora de endotelina. | |
ID28460A (id) | Komposisi dan metoda untuk perlakuan dan pencegahan penyakit tulang dengan menggunakan tocotrienol | |
BR9305961A (pt) | Compostos utilizáveis em produtos de contraste para radiografia | |
DK0674902T3 (da) | Sammensætninger til forbedring af immunreaktionen | |
DE69730796D1 (de) | Naphthylverbindungen, Zusammensetzungen und Verfahren | |
ATE278684T1 (de) | Benzo(b)thiophen-verbindungen, zwischenprodukte, verfahren und zusammensetzungen | |
ATE247101T1 (de) | Benzothiophenderivate, zwischenprodukte, verfahren, zubereitungen und methoden | |
EP1084108A4 (en) | SPLA 2 INHIBITORS FOR THE TREATMENT OF DISEASES | |
ATE245637T1 (de) | Benzothiophenverbindungen, zubereitungen und verfahren | |
DE69724548D1 (de) | Substituierte 2,3-Aryl-Benzothiophene und ihre östrogene Aktivität | |
ATE244230T1 (de) | Dihydrobenzofluorenverbindungen, zwischenprodukte,zusammensetzungen und methode | |
ATE259361T1 (de) | Benzothiophenverbindungen, zwischenprodukte, zusammensetzungen und methode | |
PT832883E (pt) | Compostos de tetrahidrobenzo(a)fluoreno e metodos de uso | |
DE69711528D1 (de) | Naphthofluorenverbindungen, Zwischenverbindungen, Zusammensetzungen und Verfahren |